Publication | Closed Access

Combined effects of terazosin and genistein on a metastatic, hormone-independent human prostate cancer cell line

UrologyGenitourinary CancerMedicinePharmacologyCombined EffectsPharmacotherapyAnti-cancer AgentProstatic DiseaseOncologyEndocrine-related Cancer